| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracellular Signaling Peptides and Proteins | 35 | 2015 | 2892 | 3.100 |
Why?
|
| Cysteine Endopeptidases | 14 | 2015 | 542 | 1.940 |
Why?
|
| Liver Regeneration | 6 | 2024 | 214 | 1.940 |
Why?
|
| NF-kappa B | 34 | 2015 | 2493 | 1.690 |
Why?
|
| Endothelium, Vascular | 36 | 2013 | 4427 | 1.590 |
Why?
|
| Nuclear Proteins | 29 | 2014 | 5804 | 1.530 |
Why?
|
| Proteins | 24 | 2006 | 6009 | 1.390 |
Why?
|
| DNA-Binding Proteins | 31 | 2014 | 9615 | 1.310 |
Why?
|
| Muscle, Smooth, Vascular | 13 | 2015 | 1493 | 1.270 |
Why?
|
| Arteriosclerosis | 5 | 2016 | 1055 | 1.180 |
Why?
|
| Hepatectomy | 5 | 2024 | 588 | 1.130 |
Why?
|
| Tumor Necrosis Factor-alpha | 39 | 2016 | 4352 | 1.000 |
Why?
|
| Apoptosis | 27 | 2015 | 9523 | 0.960 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 10 | 2013 | 1406 | 0.870 |
Why?
|
| Aorta | 10 | 2016 | 2045 | 0.810 |
Why?
|
| Models, Animal | 5 | 2024 | 2120 | 0.760 |
Why?
|
| Graft Rejection | 22 | 2015 | 4492 | 0.590 |
Why?
|
| Liver | 7 | 2024 | 7577 | 0.580 |
Why?
|
| Kidney Tubules, Proximal | 2 | 2012 | 386 | 0.560 |
Why?
|
| I-kappa B Proteins | 6 | 2005 | 210 | 0.540 |
Why?
|
| Transfection | 19 | 2010 | 5755 | 0.530 |
Why?
|
| Transplantation, Heterologous | 16 | 1999 | 2393 | 0.520 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 9 | 1991 | 897 | 0.520 |
Why?
|
| Interferon-gamma | 15 | 2021 | 3160 | 0.520 |
Why?
|
| Inflammation | 13 | 2024 | 10873 | 0.510 |
Why?
|
| Islets of Langerhans | 5 | 2003 | 1351 | 0.490 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 334 | 0.470 |
Why?
|
| Animals | 95 | 2024 | 169246 | 0.430 |
Why?
|
| Interferon-beta | 2 | 2014 | 349 | 0.430 |
Why?
|
| Transplantation, Homologous | 12 | 2016 | 4833 | 0.420 |
Why?
|
| Zinc Fingers | 5 | 2005 | 577 | 0.420 |
Why?
|
| Peripheral Arterial Disease | 1 | 2024 | 1304 | 0.400 |
Why?
|
| Interleukin-6 | 6 | 2016 | 3228 | 0.400 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 178 | 0.400 |
Why?
|
| Mice, Inbred BALB C | 13 | 2016 | 6231 | 0.400 |
Why?
|
| Tunica Intima | 3 | 2016 | 459 | 0.390 |
Why?
|
| Cytokines | 19 | 2024 | 7453 | 0.390 |
Why?
|
| Dermis | 1 | 2013 | 203 | 0.380 |
Why?
|
| Liver Failure | 2 | 2005 | 252 | 0.380 |
Why?
|
| Microbubbles | 2 | 2024 | 137 | 0.380 |
Why?
|
| Adenoviridae | 12 | 2015 | 1092 | 0.380 |
Why?
|
| Cells, Cultured | 26 | 2015 | 19015 | 0.370 |
Why?
|
| Hyperplasia | 6 | 2024 | 1151 | 0.360 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2012 | 268 | 0.350 |
Why?
|
| Lymphocyte Activation | 12 | 1996 | 5505 | 0.330 |
Why?
|
| Graft Survival | 10 | 2006 | 3887 | 0.330 |
Why?
|
| Cell Proliferation | 10 | 2024 | 10474 | 0.330 |
Why?
|
| Hepatocytes | 7 | 2015 | 1247 | 0.320 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 874 | 0.310 |
Why?
|
| Receptors, Antigen, T-Cell | 8 | 1991 | 2568 | 0.310 |
Why?
|
| Mice | 39 | 2024 | 82029 | 0.310 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 1805 | 0.310 |
Why?
|
| Atherosclerosis | 3 | 2014 | 3433 | 0.310 |
Why?
|
| PPAR alpha | 1 | 2009 | 177 | 0.300 |
Why?
|
| Endothelial Cells | 6 | 2020 | 3589 | 0.290 |
Why?
|
| Gene Expression Regulation | 12 | 2014 | 11928 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 24 | 2004 | 9263 | 0.280 |
Why?
|
| Cattle | 9 | 2013 | 3819 | 0.280 |
Why?
|
| Cytoprotection | 6 | 2014 | 200 | 0.270 |
Why?
|
| Ubiquitin | 2 | 2015 | 843 | 0.270 |
Why?
|
| Receptors, Tumor Necrosis Factor | 4 | 2002 | 587 | 0.270 |
Why?
|
| Lipid Metabolism | 2 | 2015 | 1904 | 0.270 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2015 | 379 | 0.270 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2010 | 1124 | 0.260 |
Why?
|
| Blood-Brain Barrier | 2 | 2024 | 1034 | 0.260 |
Why?
|
| U937 Cells | 3 | 2014 | 260 | 0.250 |
Why?
|
| Complement System Proteins | 6 | 2020 | 738 | 0.250 |
Why?
|
| Minor Histocompatibility Antigens | 5 | 2013 | 303 | 0.240 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 1461 | 0.240 |
Why?
|
| E-Selectin | 6 | 1998 | 577 | 0.230 |
Why?
|
| RNA, Small Interfering | 7 | 2024 | 3428 | 0.230 |
Why?
|
| Heme Oxygenase (Decyclizing) | 2 | 2002 | 165 | 0.230 |
Why?
|
| Immunity, Innate | 3 | 2015 | 3080 | 0.230 |
Why?
|
| Gene Transfer Techniques | 3 | 2024 | 1207 | 0.220 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2016 | 702 | 0.220 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2013 | 1901 | 0.220 |
Why?
|
| Swine | 15 | 2006 | 5995 | 0.210 |
Why?
|
| T-Lymphocytes | 13 | 1997 | 10266 | 0.210 |
Why?
|
| Carotid Arteries | 3 | 2015 | 942 | 0.210 |
Why?
|
| Reperfusion Injury | 1 | 2009 | 1039 | 0.210 |
Why?
|
| Up-Regulation | 7 | 2015 | 4146 | 0.200 |
Why?
|
| Interleukin-1 | 7 | 1999 | 1252 | 0.200 |
Why?
|
| Protein Biosynthesis | 4 | 2003 | 2094 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 22379 | 0.200 |
Why?
|
| Homeodomain Proteins | 3 | 2001 | 2429 | 0.200 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2001 | 1839 | 0.200 |
Why?
|
| Autoimmune Diseases | 2 | 2014 | 2257 | 0.200 |
Why?
|
| Gelatin | 1 | 2024 | 231 | 0.200 |
Why?
|
| Signal Transduction | 12 | 2024 | 23645 | 0.190 |
Why?
|
| Islets of Langerhans Transplantation | 2 | 2004 | 748 | 0.190 |
Why?
|
| CD40 Ligand | 1 | 2003 | 528 | 0.190 |
Why?
|
| Renal Artery | 1 | 2003 | 354 | 0.180 |
Why?
|
| Kidney Transplantation | 10 | 2005 | 4262 | 0.180 |
Why?
|
| Intercellular Adhesion Molecule-1 | 3 | 2013 | 1134 | 0.180 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2024 | 538 | 0.180 |
Why?
|
| Repressor Proteins | 3 | 2001 | 2982 | 0.180 |
Why?
|
| Monocytes | 5 | 2010 | 2605 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2024 | 248 | 0.170 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 895 | 0.170 |
Why?
|
| Gene Expression | 9 | 2009 | 7598 | 0.170 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 322 | 0.170 |
Why?
|
| Energy Metabolism | 2 | 2011 | 2907 | 0.170 |
Why?
|
| Lipopolysaccharides | 5 | 2014 | 2219 | 0.170 |
Why?
|
| bcl-X Protein | 4 | 2003 | 412 | 0.170 |
Why?
|
| Protein Engineering | 1 | 2003 | 553 | 0.160 |
Why?
|
| Nitric Oxide | 4 | 2010 | 2146 | 0.160 |
Why?
|
| Liver Transplantation | 2 | 2009 | 2401 | 0.160 |
Why?
|
| Luciferases | 3 | 2013 | 713 | 0.160 |
Why?
|
| Diffusion of Innovation | 1 | 2024 | 724 | 0.160 |
Why?
|
| Rats | 19 | 2024 | 23760 | 0.160 |
Why?
|
| Interferons | 2 | 2020 | 720 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2012 | 3703 | 0.150 |
Why?
|
| Macrophages | 2 | 2010 | 5799 | 0.150 |
Why?
|
| Caspase 8 | 3 | 2009 | 198 | 0.150 |
Why?
|
| Killer Cells, Natural | 3 | 2004 | 2211 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2014 | 16045 | 0.140 |
Why?
|
| Vasculitis | 2 | 2001 | 525 | 0.140 |
Why?
|
| Galactosamine | 2 | 2009 | 26 | 0.140 |
Why?
|
| Recombinant Proteins | 7 | 2003 | 6514 | 0.140 |
Why?
|
| Forecasting | 2 | 2024 | 2945 | 0.130 |
Why?
|
| Antigens, CD | 4 | 1997 | 4035 | 0.130 |
Why?
|
| Humans | 83 | 2024 | 768166 | 0.130 |
Why?
|
| Thiocarbamates | 1 | 1995 | 30 | 0.130 |
Why?
|
| Phosphorylation | 5 | 2014 | 8317 | 0.130 |
Why?
|
| Genetic Vectors | 8 | 2010 | 3402 | 0.130 |
Why?
|
| Cell Movement | 4 | 2014 | 5210 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2024 | 15832 | 0.130 |
Why?
|
| Cyclin A | 1 | 2015 | 59 | 0.120 |
Why?
|
| Mice, Knockout | 5 | 2015 | 14488 | 0.120 |
Why?
|
| Adenoviruses, Human | 1 | 1997 | 257 | 0.120 |
Why?
|
| Endothelium | 1 | 1997 | 768 | 0.120 |
Why?
|
| Cyclin E | 1 | 2015 | 155 | 0.120 |
Why?
|
| Polyvinyl Alcohol | 1 | 2015 | 74 | 0.120 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2024 | 1250 | 0.120 |
Why?
|
| Mice, Inbred CBA | 2 | 1993 | 439 | 0.120 |
Why?
|
| RNA, Messenger | 9 | 2015 | 12800 | 0.120 |
Why?
|
| Hydrogen Peroxide | 3 | 2009 | 740 | 0.120 |
Why?
|
| Electrochemical Techniques | 1 | 2015 | 94 | 0.120 |
Why?
|
| Necrosis | 3 | 2009 | 1616 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2909 | 0.110 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2024 | 1456 | 0.110 |
Why?
|
| Cytotoxins | 1 | 2015 | 154 | 0.110 |
Why?
|
| Enzyme Activation | 4 | 2010 | 3590 | 0.110 |
Why?
|
| Mice, Inbred DBA | 2 | 1991 | 624 | 0.110 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2020 | 8128 | 0.110 |
Why?
|
| Interleukin-3 | 2 | 1991 | 425 | 0.110 |
Why?
|
| Pyrrolidines | 1 | 1995 | 340 | 0.110 |
Why?
|
| Cyclin D1 | 1 | 2015 | 453 | 0.110 |
Why?
|
| Fas-Associated Death Domain Protein | 2 | 2004 | 27 | 0.110 |
Why?
|
| STAT1 Transcription Factor | 1 | 2014 | 343 | 0.110 |
Why?
|
| Single-Cell Analysis | 1 | 2024 | 2540 | 0.100 |
Why?
|
| Chromosome Mapping | 1 | 2001 | 4620 | 0.100 |
Why?
|
| Gene Silencing | 2 | 2010 | 1505 | 0.100 |
Why?
|
| Antilymphocyte Serum | 2 | 1998 | 492 | 0.100 |
Why?
|
| Heme Oxygenase-1 | 3 | 2014 | 364 | 0.100 |
Why?
|
| Membrane Glycoproteins | 2 | 2014 | 3711 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2015 | 5027 | 0.100 |
Why?
|
| Replication Protein C | 3 | 2001 | 26 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 4580 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 18065 | 0.100 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 467 | 0.100 |
Why?
|
| Cycloheximide | 2 | 2004 | 341 | 0.100 |
Why?
|
| Muromonab-CD3 | 7 | 1993 | 104 | 0.090 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 18349 | 0.090 |
Why?
|
| Cerebral Ventricles | 1 | 2014 | 550 | 0.090 |
Why?
|
| Caspases | 3 | 2004 | 882 | 0.090 |
Why?
|
| Transcription, Genetic | 4 | 2011 | 7608 | 0.090 |
Why?
|
| Heart Transplantation | 5 | 1999 | 3301 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 3 | 1995 | 1613 | 0.090 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 1104 | 0.090 |
Why?
|
| Cell Division | 2 | 2009 | 4473 | 0.090 |
Why?
|
| Microcirculation | 2 | 2013 | 1281 | 0.090 |
Why?
|
| Transcriptional Activation | 3 | 2003 | 1750 | 0.090 |
Why?
|
| Down-Regulation | 3 | 2021 | 2937 | 0.090 |
Why?
|
| Encephalitis | 1 | 2014 | 441 | 0.090 |
Why?
|
| Endovascular Procedures | 1 | 2024 | 2216 | 0.090 |
Why?
|
| Veins | 2 | 2012 | 769 | 0.090 |
Why?
|
| Viruses | 1 | 2014 | 373 | 0.080 |
Why?
|
| Transcription Factors | 3 | 2011 | 12168 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 3610 | 0.080 |
Why?
|
| Neointima | 1 | 2010 | 133 | 0.080 |
Why?
|
| Chemokine CCL2 | 2 | 2005 | 605 | 0.080 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 706 | 0.080 |
Why?
|
| Saphenous Vein | 2 | 2010 | 519 | 0.080 |
Why?
|
| Oxidants | 1 | 2009 | 168 | 0.080 |
Why?
|
| Organ Transplantation | 1 | 1999 | 1176 | 0.080 |
Why?
|
| Protein Kinase C-delta | 1 | 2009 | 115 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 2474 | 0.080 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2001 | 4528 | 0.080 |
Why?
|
| Registries | 1 | 2024 | 8375 | 0.070 |
Why?
|
| Genomics | 1 | 2024 | 5926 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 182 | 0.070 |
Why?
|
| Glycosylation | 1 | 2010 | 1100 | 0.070 |
Why?
|
| Antioxidants | 1 | 1995 | 1673 | 0.070 |
Why?
|
| Dogs | 3 | 2024 | 3845 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2010 | 2149 | 0.070 |
Why?
|
| Blood Vessels | 2 | 2006 | 1110 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 1369 | 0.070 |
Why?
|
| Binding Sites | 2 | 2011 | 6020 | 0.070 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2006 | 262 | 0.070 |
Why?
|
| Vasodilation | 1 | 2010 | 967 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 2457 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3772 | 0.060 |
Why?
|
| Tissue Donors | 1 | 1996 | 2381 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 5889 | 0.060 |
Why?
|
| Interleukin-8 | 3 | 1998 | 704 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 1997 | 257 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 3 | 1991 | 1886 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2012 | 2885 | 0.060 |
Why?
|
| Caspase 3 | 2 | 2004 | 730 | 0.060 |
Why?
|
| Cricetinae | 4 | 1999 | 2423 | 0.060 |
Why?
|
| Mice, Nude | 1 | 1991 | 3623 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2014 | 1305 | 0.060 |
Why?
|
| HeLa Cells | 2 | 2005 | 3074 | 0.060 |
Why?
|
| Membrane Proteins | 4 | 2014 | 7876 | 0.060 |
Why?
|
| Caspase 6 | 1 | 2004 | 15 | 0.060 |
Why?
|
| Plasmids | 3 | 2001 | 2269 | 0.060 |
Why?
|
| Nephritis | 1 | 2005 | 147 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2010 | 1418 | 0.060 |
Why?
|
| Valine | 1 | 2006 | 410 | 0.060 |
Why?
|
| Transcription Factor RelA | 3 | 2002 | 252 | 0.060 |
Why?
|
| Rats, Inbred Strains | 4 | 2003 | 2087 | 0.060 |
Why?
|
| Acute Disease | 2 | 2014 | 7243 | 0.060 |
Why?
|
| Body Temperature | 3 | 1991 | 780 | 0.060 |
Why?
|
| Coronary Vessels | 3 | 2010 | 3124 | 0.050 |
Why?
|
| Mice, Inbred A | 1 | 2003 | 245 | 0.050 |
Why?
|
| Lymphocyte Depletion | 2 | 2004 | 605 | 0.050 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2006 | 428 | 0.050 |
Why?
|
| Thrombospondins | 1 | 2024 | 196 | 0.050 |
Why?
|
| Fatty Liver | 1 | 2009 | 809 | 0.050 |
Why?
|
| Cell Line | 5 | 2020 | 15597 | 0.050 |
Why?
|
| Brain Chemistry | 6 | 1984 | 958 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2003 | 119 | 0.050 |
Why?
|
| Genes, Reporter | 2 | 1997 | 1524 | 0.050 |
Why?
|
| Bone Marrow Cells | 1 | 2010 | 2414 | 0.050 |
Why?
|
| Motor Activity | 5 | 1991 | 2711 | 0.050 |
Why?
|
| Immunohistochemistry | 4 | 2006 | 11095 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2010 | 3514 | 0.050 |
Why?
|
| Gene Regulatory Networks | 1 | 2011 | 1752 | 0.050 |
Why?
|
| Protective Agents | 1 | 2003 | 150 | 0.050 |
Why?
|
| Cadherins | 1 | 2007 | 905 | 0.050 |
Why?
|
| Genetic Engineering | 3 | 1997 | 936 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2024 | 65371 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2828 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2011 | 5797 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2002 | 514 | 0.050 |
Why?
|
| Coculture Techniques | 3 | 2020 | 1340 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8744 | 0.050 |
Why?
|
| Thromboplastin | 1 | 2003 | 289 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2007 | 2932 | 0.050 |
Why?
|
| Aortic Rupture | 1 | 2024 | 322 | 0.050 |
Why?
|
| Drug Delivery Systems | 2 | 2024 | 2232 | 0.050 |
Why?
|
| Fibroblast Growth Factor 1 | 1 | 2020 | 53 | 0.050 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2024 | 373 | 0.050 |
Why?
|
| Carbon Monoxide | 1 | 2004 | 560 | 0.050 |
Why?
|
| Genes | 2 | 1999 | 1824 | 0.040 |
Why?
|
| Male | 21 | 2024 | 364719 | 0.040 |
Why?
|
| Fas Ligand Protein | 1 | 2001 | 216 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 911 | 0.040 |
Why?
|
| Chronic Disease | 2 | 2014 | 9384 | 0.040 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2013 | 1899 | 0.040 |
Why?
|
| Tetrazoles | 1 | 2006 | 923 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2004 | 3447 | 0.040 |
Why?
|
| Gene Expression Profiling | 3 | 2024 | 9538 | 0.040 |
Why?
|
| Interleukin-2 | 6 | 1992 | 1895 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 2631 | 0.040 |
Why?
|
| Insulin | 3 | 2024 | 6607 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 410 | 0.040 |
Why?
|
| Ubiquitination | 2 | 2015 | 1009 | 0.040 |
Why?
|
| Brain | 6 | 2024 | 27360 | 0.040 |
Why?
|
| Lactates | 2 | 1981 | 401 | 0.040 |
Why?
|
| Genes, Dominant | 3 | 1998 | 855 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 6082 | 0.040 |
Why?
|
| Agranulocytosis | 1 | 1979 | 98 | 0.040 |
Why?
|
| Syndrome | 4 | 1993 | 3272 | 0.040 |
Why?
|
| NFATC Transcription Factors | 1 | 2001 | 393 | 0.040 |
Why?
|
| Sucrose | 2 | 1991 | 157 | 0.040 |
Why?
|
| Lymphotoxin-alpha | 1 | 1998 | 94 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 5341 | 0.040 |
Why?
|
| Kidney | 2 | 2005 | 7064 | 0.040 |
Why?
|
| Sp1 Transcription Factor | 1 | 1999 | 143 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2003 | 1826 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2020 | 527 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2010 | 9561 | 0.040 |
Why?
|
| Vascular Diseases | 1 | 2006 | 1162 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2004 | 1441 | 0.040 |
Why?
|
| Carrier Proteins | 2 | 2020 | 4937 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 1999 | 866 | 0.040 |
Why?
|
| Cell Communication | 2 | 2002 | 1660 | 0.030 |
Why?
|
| Immunogenetics | 1 | 1997 | 62 | 0.030 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 74 | 0.030 |
Why?
|
| Cell Cycle Proteins | 2 | 2005 | 3445 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2013 | 3803 | 0.030 |
Why?
|
| Granulocytes | 1 | 1979 | 551 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 627 | 0.030 |
Why?
|
| Pyridazines | 4 | 1984 | 203 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13586 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2020 | 725 | 0.030 |
Why?
|
| Antibodies | 3 | 2007 | 2421 | 0.030 |
Why?
|
| Trioses | 1 | 1976 | 3 | 0.030 |
Why?
|
| Diphosphoglyceric Acids | 1 | 1976 | 31 | 0.030 |
Why?
|
| Ischemia | 1 | 2005 | 1900 | 0.030 |
Why?
|
| Dihydroxyacetone | 1 | 1976 | 8 | 0.030 |
Why?
|
| Regeneration | 1 | 2005 | 1524 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2008 | 317 | 0.030 |
Why?
|
| Genes, jun | 1 | 1995 | 69 | 0.030 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1997 | 279 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1997 | 826 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1995 | 79 | 0.030 |
Why?
|
| Biological Transport | 1 | 2020 | 2085 | 0.030 |
Why?
|
| Calcium | 1 | 2009 | 5792 | 0.030 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2002 | 617 | 0.030 |
Why?
|
| Time Factors | 6 | 2024 | 40218 | 0.030 |
Why?
|
| Genes, Bacterial | 2 | 1991 | 1076 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2981 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1676 | 0.030 |
Why?
|
| Th2 Cells | 2 | 1997 | 1078 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6124 | 0.030 |
Why?
|
| Diffuse Axonal Injury | 1 | 2014 | 49 | 0.030 |
Why?
|
| Receptors, Vasopressin | 1 | 2014 | 106 | 0.030 |
Why?
|
| Thioredoxins | 1 | 1995 | 202 | 0.030 |
Why?
|
| Diarrhea | 2 | 1991 | 1320 | 0.030 |
Why?
|
| Histocompatibility | 1 | 2015 | 321 | 0.030 |
Why?
|
| Monitoring, Immunologic | 2 | 1990 | 100 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2002 | 1388 | 0.030 |
Why?
|
| Genome, Viral | 1 | 1997 | 674 | 0.030 |
Why?
|
| Laparotomy | 2 | 1973 | 458 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 20227 | 0.030 |
Why?
|
| Platelet Aggregation | 1 | 1996 | 769 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2005 | 10101 | 0.030 |
Why?
|
| Leukemia | 1 | 1981 | 1519 | 0.030 |
Why?
|
| Prosencephalon | 1 | 2014 | 305 | 0.020 |
Why?
|
| Skin | 1 | 2006 | 4503 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 563 | 0.020 |
Why?
|
| Shock, Hemorrhagic | 2 | 1984 | 224 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 1979 | 1309 | 0.020 |
Why?
|
| Histamine Release | 1 | 1991 | 134 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 1703 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 792 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3109 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 1993 | 915 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2014 | 381 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1993 | 564 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4415 | 0.020 |
Why?
|
| Species Specificity | 2 | 1995 | 2415 | 0.020 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2010 | 5 | 0.020 |
Why?
|
| HLA-DR Antigens | 1 | 1993 | 609 | 0.020 |
Why?
|
| Biogenic Amines | 4 | 1984 | 53 | 0.020 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 1991 | 23 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1991 | 892 | 0.020 |
Why?
|
| Air Pressure | 1 | 2010 | 75 | 0.020 |
Why?
|
| Mitochondria | 1 | 2004 | 3681 | 0.020 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 537 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1991 | 1765 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3814 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 1993 | 619 | 0.020 |
Why?
|
| Biopsy | 2 | 1993 | 6793 | 0.020 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1993 | 693 | 0.020 |
Why?
|
| RNA Interference | 2 | 2010 | 2832 | 0.020 |
Why?
|
| Female | 11 | 2024 | 397192 | 0.020 |
Why?
|
| Corticosterone | 1 | 1990 | 301 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2010 | 290 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 213 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2014 | 910 | 0.020 |
Why?
|
| Quality Control | 1 | 2012 | 836 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2009 | 80 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 2009 | 66 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2678 | 0.020 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 240 | 0.020 |
Why?
|
| Interferon Type I | 2 | 1990 | 569 | 0.020 |
Why?
|
| Child, Institutionalized | 1 | 1969 | 111 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2009 | 173 | 0.020 |
Why?
|
| Lymphatic System | 1 | 1990 | 251 | 0.020 |
Why?
|
| Hypothermia | 1 | 1990 | 189 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10760 | 0.020 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 1991 | 404 | 0.020 |
Why?
|
| Spleen | 1 | 1994 | 2295 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15662 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 297 | 0.020 |
Why?
|
| Neoplasms | 2 | 2014 | 22371 | 0.020 |
Why?
|
| Myelodysplastic Syndromes | 1 | 1997 | 1399 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 899 | 0.020 |
Why?
|
| Hodgkin Disease | 2 | 1973 | 1384 | 0.020 |
Why?
|
| Salmonella | 1 | 1987 | 125 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1991 | 4214 | 0.020 |
Why?
|
| Models, Biological | 3 | 1997 | 9495 | 0.020 |
Why?
|
| Astrocytes | 1 | 2014 | 1350 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2024 | 24315 | 0.020 |
Why?
|
| Erythrocytes | 1 | 1976 | 2418 | 0.020 |
Why?
|
| Polysomnography | 1 | 2013 | 1871 | 0.020 |
Why?
|
| Nucleotides | 1 | 2009 | 455 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 990 | 0.020 |
Why?
|
| Cell Survival | 2 | 2009 | 5777 | 0.020 |
Why?
|
| Aged | 5 | 2024 | 171504 | 0.020 |
Why?
|
| Interleukins | 1 | 1990 | 796 | 0.020 |
Why?
|
| Placebos | 1 | 1969 | 1667 | 0.020 |
Why?
|
| Antibodies, Heterophile | 2 | 1995 | 128 | 0.010 |
Why?
|
| Propidium | 1 | 2004 | 42 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2004 | 103 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2005 | 254 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2004 | 184 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2005 | 513 | 0.010 |
Why?
|
| Reperfusion | 1 | 2005 | 266 | 0.010 |
Why?
|
| Fever | 1 | 1991 | 1614 | 0.010 |
Why?
|
| Adult | 9 | 2013 | 223646 | 0.010 |
Why?
|
| Primates | 2 | 1997 | 520 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2005 | 432 | 0.010 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2004 | 200 | 0.010 |
Why?
|
| Adolescent | 5 | 2002 | 89169 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2007 | 991 | 0.010 |
Why?
|
| Lysosomes | 1 | 2009 | 938 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 1991 | 1206 | 0.010 |
Why?
|
| Catecholamines | 1 | 1984 | 389 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 740 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2005 | 617 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1987 | 1385 | 0.010 |
Why?
|
| Middle Aged | 7 | 2013 | 223492 | 0.010 |
Why?
|
| Femoral Artery | 1 | 2007 | 829 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2024 | 59629 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 1500 | 0.010 |
Why?
|
| Drug Administration Schedule | 2 | 2006 | 4860 | 0.010 |
Why?
|
| Pyrrolidinones | 1 | 1982 | 116 | 0.010 |
Why?
|
| Piracetam | 1 | 1982 | 88 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2004 | 394 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2002 | 42669 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1987 | 4168 | 0.010 |
Why?
|
| Electrophoresis | 1 | 2002 | 226 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2006 | 12252 | 0.010 |
Why?
|
| Th1 Cells | 2 | 1997 | 1042 | 0.010 |
Why?
|
| Adoptive Transfer | 1 | 2004 | 825 | 0.010 |
Why?
|
| Central Nervous System Stimulants | 1 | 1969 | 1168 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2006 | 1622 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 2006 | 806 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 2479 | 0.010 |
Why?
|
| Isoproterenol | 1 | 1981 | 398 | 0.010 |
Why?
|
| Thrombosis | 1 | 1994 | 2957 | 0.010 |
Why?
|
| Cadmium Poisoning | 1 | 1980 | 11 | 0.010 |
Why?
|
| Graft vs Host Disease | 1 | 1992 | 3049 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2004 | 1837 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 2107 | 0.010 |
Why?
|
| Lymphocytes | 2 | 2002 | 2614 | 0.010 |
Why?
|
| Marine Toxins | 1 | 1979 | 24 | 0.010 |
Why?
|
| Serotonin | 1 | 1984 | 1043 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 1679 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4938 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1996 | 11669 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2024 | 81762 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2006 | 4030 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 17140 | 0.010 |
Why?
|
| Neurotransmitter Agents | 1 | 1982 | 663 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1625 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1989 | 2100 | 0.010 |
Why?
|
| Child | 3 | 2002 | 80917 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1991 | 4206 | 0.010 |
Why?
|
| Blood Pressure | 3 | 1984 | 8543 | 0.010 |
Why?
|
| Metabolism | 1 | 1979 | 193 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2005 | 1942 | 0.010 |
Why?
|
| MAP Kinase Signaling System | 1 | 2004 | 1494 | 0.010 |
Why?
|
| Pancreatectomy | 1 | 2002 | 825 | 0.010 |
Why?
|
| Risk Factors | 1 | 2024 | 74944 | 0.010 |
Why?
|
| Pancreas | 1 | 2004 | 1700 | 0.010 |
Why?
|
| Phenotype | 3 | 2008 | 16726 | 0.010 |
Why?
|
| Mesocricetus | 1 | 1997 | 256 | 0.010 |
Why?
|
| Rabbits | 3 | 1981 | 4772 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 2496 | 0.010 |
Why?
|
| United States | 1 | 2024 | 73039 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1998 | 596 | 0.010 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 13676 | 0.010 |
Why?
|
| Nervous System | 1 | 1979 | 544 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22291 | 0.010 |
Why?
|
| Transgenes | 1 | 1998 | 1016 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1162 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2810 | 0.010 |
Why?
|
| Directed Molecular Evolution | 1 | 1996 | 165 | 0.010 |
Why?
|
| RNA | 1 | 2004 | 2720 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2002 | 1408 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1497 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2002 | 1965 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1997 | 557 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1981 | 1248 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2005 | 3139 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1998 | 1968 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 5902 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2004 | 3728 | 0.010 |
Why?
|
| Complement Activation | 1 | 1995 | 447 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1998 | 998 | 0.010 |
Why?
|
| Prednisone | 1 | 1997 | 1567 | 0.010 |
Why?
|
| Blood Gas Analysis | 2 | 1984 | 384 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36743 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2005 | 4413 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2002 | 2167 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1997 | 1393 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 26379 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12465 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8509 | 0.010 |
Why?
|
| Platelet Activation | 1 | 1995 | 644 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 1973 | 287 | 0.010 |
Why?
|
| Splenectomy | 1 | 1973 | 392 | 0.010 |
Why?
|
| Porins | 1 | 1991 | 78 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1981 | 6316 | 0.010 |
Why?
|
| Blood Transfusion, Intrauterine | 1 | 1970 | 28 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 417 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1997 | 3096 | 0.010 |
Why?
|
| Meningitis | 1 | 1991 | 219 | 0.010 |
Why?
|
| Blood Glucose | 2 | 1984 | 6430 | 0.010 |
Why?
|
| Body Weight | 1 | 1981 | 4627 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1998 | 3740 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 1997 | 1854 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 1990 | 218 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 1991 | 239 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 1057 | 0.010 |
Why?
|
| Immunization Schedule | 1 | 1991 | 228 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 863 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1998 | 3655 | 0.010 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1990 | 355 | 0.000 |
Why?
|
| Blood Coagulation | 1 | 1995 | 1162 | 0.000 |
Why?
|
| Nephritis, Hereditary | 1 | 1989 | 78 | 0.000 |
Why?
|
| Antidepressive Agents | 1 | 1981 | 2913 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15454 | 0.000 |
Why?
|
| Cadaver | 1 | 1992 | 1363 | 0.000 |
Why?
|
| Amniotic Fluid | 1 | 1970 | 381 | 0.000 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1989 | 133 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15948 | 0.000 |
Why?
|
| Growth Substances | 1 | 1990 | 759 | 0.000 |
Why?
|
| Morpholines | 2 | 1981 | 584 | 0.000 |
Why?
|
| DNA Restriction Enzymes | 1 | 1987 | 548 | 0.000 |
Why?
|
| Open Reading Frames | 1 | 1991 | 818 | 0.000 |
Why?
|
| Hypertension | 2 | 1989 | 8616 | 0.000 |
Why?
|
| Operon | 1 | 1987 | 371 | 0.000 |
Why?
|
| Young Adult | 1 | 2013 | 60066 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 1305 | 0.000 |
Why?
|
| Prospective Studies | 2 | 2006 | 54926 | 0.000 |
Why?
|
| Hypotension | 1 | 1991 | 888 | 0.000 |
Why?
|
| Prognosis | 2 | 1989 | 30010 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 39348 | 0.000 |
Why?
|
| Interprofessional Relations | 1 | 1969 | 997 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1991 | 3956 | 0.000 |
Why?
|
| Norepinephrine | 1 | 1984 | 898 | 0.000 |
Why?
|
| Electroshock | 1 | 1981 | 120 | 0.000 |
Why?
|
| Ascorbic Acid | 1 | 1984 | 658 | 0.000 |
Why?
|
| Omentum | 1 | 1961 | 168 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 1 | 1979 | 7477 | 0.000 |
Why?
|
| Base Sequence | 1 | 1991 | 12421 | 0.000 |
Why?
|
| Pilot Projects | 1 | 1992 | 8741 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 13421 | 0.000 |
Why?
|
| Adenosine | 1 | 1984 | 820 | 0.000 |
Why?
|
| Infant | 1 | 1981 | 36535 | 0.000 |
Why?
|
| Patient Care Team | 1 | 1969 | 2523 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 17622 | 0.000 |
Why?
|
| Stomach Neoplasms | 1 | 1948 | 1481 | 0.000 |
Why?
|
| Intestinal Obstruction | 1 | 1961 | 433 | 0.000 |
Why?
|
| Dopamine | 1 | 1984 | 1592 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1981 | 1419 | 0.000 |
Why?
|
| Disease | 1 | 1961 | 675 | 0.000 |
Why?
|
| Sex Factors | 1 | 1989 | 10632 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1969 | 8054 | 0.000 |
Why?
|
| Hepatomegaly | 1 | 1973 | 84 | 0.000 |
Why?
|
| Splenic Neoplasms | 1 | 1973 | 97 | 0.000 |
Why?
|
| Splenomegaly | 1 | 1973 | 192 | 0.000 |
Why?
|
| Lymphography | 1 | 1973 | 189 | 0.000 |
Why?
|
| Glucose | 1 | 1984 | 4352 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 1991 | 26422 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1973 | 1627 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1979 | 6314 | 0.000 |
Why?
|
| Liver Neoplasms | 1 | 1973 | 4362 | 0.000 |
Why?
|